SEC Form 4 · accession 0000891293-15-000051
CTI BIOPHARMA CORP · CTIC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard L Love
Director
Period of report
Sep 30, 2015
Accepted (ET)
Oct 1, 2015 · 7:13 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000891293
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Sep 30, 2015 | S | 7,411 | $1.45 | D | 536,698 | D | |
| Common Stock | Sep 30, 2015 | S | 3,149 | $1.455 | D | 533,549 | D | |
| Common Stock | Sep 30, 2015 | S | 100 | $1.4575 | D | 533,449 | D | |
| Common Stock | Sep 30, 2015 | S | 700 | $1.4579 | D | 532,749 | D | |
| Common Stock | Sep 30, 2015 | S | 2,200 | $1.46 | D | 530,549 | D | |
| Common Stock | Sep 30, 2015 | S | 100 | $1.465 | D | 530,449 | D |
Table II — derivative securities
No Table II lines on this filing.